Empiric use of linezolid in febrile hematology and hematopoietic stem cell transplantation patients colonized with vancomycin-resistant Enterococcus spp

International Journal of Infectious Diseases

Volumn 33, Issue , 2015, Pages e171-e176

  Lisboa, Luiz F ^a   Miranda, Bianca G ^b   Vieira, Marjorie B ^b   Dulley, Frederico L ^b   Fonseca, Guilherme G ^b   Guimarães, Thais ^b   Levin, Anna S ^b   Shikanai Yasuda, Maria A ^b   Costa, Silvia F ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bone marrow transplant; Hematology; Linezolid; VRE

Indexed keywords

LINEZOLID; ANTIINFECTIVE AGENT;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BLOODSTREAM INFECTION; CONTROLLED STUDY; DEATH; DRUG USE; FEBRILE NEUTROPENIA; FEVER; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NEUTROPENIA; PRESCRIPTION; RISK FACTOR; SURVIVAL RATE; VANCOMYCIN RESISTANT ENTEROCOCCUS; ADOLESCENT; AGED; ANTIBIOTIC RESISTANCE; CHILD; DRUG EFFECTS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOLOGIC DISEASES; HOSPITAL MORTALITY; INFANT; MALE; MIDDLE AGED; PRESCHOOL CHILD; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL MORTALITY; HUMANS; INFANT; LINEZOLID; MALE; MIDDLE AGED; NEUTROPENIA; RETROSPECTIVE STUDIES; RISK FACTORS; VANCOMYCIN RESISTANCE; VANCOMYCIN-RESISTANT ENTEROCOCCI; YOUNG ADULT;

EID: 84923614621     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2015.02.001     Document Type: Article

References (37)

1. Sader H.S., Moet G.J., Jones R.N. Antimicrobial resistance among Gram-positive bacteria isolated in Latin American hospitals. J Chemother 2009, 21:611-620.
2. Zhao C., Sun H., Wang H., Liu Y., Hu B., Yu Y., et al. Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (2005-2010). Diagn Microbiol Infect Dis 2012, 73:174-181.
3. Irfan S., Idrees F., Mehraj V., Habib F., Adil S., Hasan R. Emergence of carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study. BMC Infect Dis 2008, 8:80.
4. Vydra J., Shanley R.M., George I., Ustun C., Smith A.R., Weisdorf D.J., et al. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012, 55:764-770.
5. Taur Y., Xavier J.B., Lipuma L., Ubeda C., Goldberg J., Gobourne A., et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012, 55:905-914.
6. Matar M.J., Tarrand J., Raad I., Rolston K.V. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control 2006, 34:534-536.
7. Rolston K.V., Jiang Y., Matar M. VRE fecal colonization/infection in cancer patients. Bone Marrow Transplant 2007, 39:567-568.
8. Ubeda C., Taur Y., Jenq R.R., Equinda M.J., Son T., Samstein M., et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 2010, 120:4332-4341.
9. Miyazaki S., Fujikawa T., Kobayashi I., Matsumoto T., Tateda K., Yamaguchi K. Development of systemic bacteraemia after oral inoculation of vancomycin-resistant enterococci in mice. J Med Microbiol 2001, 50:695-701.
10. DiazGranados C.A., Jernigan J.A. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis 2005, 191:588-595.
11. DiazGranados C.A., Zimmer S.M., Klein M., Jernigan J.A. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 2005, 41:327-333.
12. Ghanem G., Hachem R., Jiang Y., Chemaly R.F., Raad I. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients. Infect Control Hosp Epidemiol 2007, 28:1054-1059.
13. Kraft S., Mackler E., Schlickman P., Welch K., Depestel D.D. Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients. Support Care Cancer 2011, 19:1969-1974.
14. Suppli M., Aabenhus R., Harboe Z.B., Andersen L.P., Tvede M., Jensen J.U. Mortality in enterococcal bloodstream infections increases with inappropriate antimicrobial therapy. Clin Microbiol Infect 2011, 17:1078-1083.
15. Avery R., Kalaycio M., Pohlman B., Sobecks R., Kuczkowski E., Andresen S., et al. Early vancomycin-resistant Enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course. Bone Marrow Transplant 2005, 35:497-499.
16. Dubberke E.R., Hollands J.M., Georgantopoulos P., Augustin K., DiPersio J.F., Mundy L.M., et al. Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker?. Bone Marrow Transplant 2006, 38:813-819.
17. Todeschini G., Tecchio C., Borghero C., D'Emilio A., Pegoraro E., de Lalla F., et al. Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies. J Infect 2006, 53:266-273.
18. Liss B.J., Vehreschild J.J., Cornely O.A., Hallek M., Fatkenheuer G., Wisplinghoff H., et al. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection 2012, 40:613-619.
19. Weinstock D.M., Conlon M., Lovino C., Aubrey T., Gudiol C., Riedel E., et al. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant Enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2007, 13:615-621.
20. Dibo I., Pillai S.K., Gold H.S., Baer M.R., Wetzler M., Slack J.L., et al. Linezolid-resistant Enterococcus faecalis isolated from a cord blood transplant recipient. J Clin Microbiol 2004, 42:1843-1845.
21. Fossati M., Cappelli B., Biral E., Chiesa R., Biffi A., Ossi C., et al. Fatal vancomycin- and linezolid-resistant Enterococcus faecium sepsis in a child undergoing allogeneic haematopoietic stem cell transplantation for beta-thalassaemia major. J Med Microbiol 2010, 59(Pt 7):839-842.
22. Scheetz M.H., Knechtel S.A., Malczynski M., Postelnick M.J., Qi C. Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption. Antimicrob Agents Chemother 2008, 52:2256-2259.
23. Hughes W.T., Armstrong D., Bodey G.P., Brown A.E., Edwards J.E., Feld R., et al. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis 1997, 25:551-573.
24. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16:128-140.
25. Bach P.B., Malak S.F., Jurcic J., Gelfand S.E., Eagan J., Little C., Sepkowitz K.A. Impact of infection by vancomycin-resistant Enterococcus on survival and resource utilization for patients with leukemia. Infect Control Hosp Epidemiol 2002, 23:471-474.
26. Klastersky J., Paesmans M., Rubenstein E.B., Boyer M., Elting L., Feld R., et al. The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000, 18:3038-3051.
27. Kamboj M., Chung D., Seo S.K., Pamer E.G., Sepkowitz K.A., Jakubowski A.A., Papanicolaou G. The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Biol Blood Marrow Transplant 2010, 16:1576-1581.
28. Freifeld A.G., Bow E.J., Sepkowitz K.A., Boeckh M.J., Ito J.I., Mullen C.A., et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011, 52:e56-e93.
29. Bossaer J.B., Hall P.D., Garrett-Mayer E. Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. Support Care Cancer 2010, 19:231-237.
30. Brandl K., Plitas G., Mihu C.N., Ubeda C., Jia T., Fleisher M., et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 2008, 455:804-807.
31. Kinnebrew M.A., Ubeda C., Zenewicz L.A., Smith N., Flavell R.A., Pamer E.G. Bacterial flagellin stimulates toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. J Infect Dis 2010, 201:534-543.
32. Olivier C.N., Blake R.K., Steed L.L., Salgado C.D. Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE. Infect Control Hosp Epidemiol 2008, 29:404-409.
33. Hogan H.L., Hachem R.Y., Neuhauser M., Raad I.I., Coyle E. Clinical experience of linezolid in bone marrow transplantation patients. J Pharm Pract 2010, 23:352-357.
34. Cohen N., Mihu C.N., Seo S.K., Chung D., Chou J., Heller G., Papanicolaou G.A. Hematologic safety profile of linezolid in the early periengraftment period after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2009, 15:1337-1341.
35. McKinnell J.A., Patel M., Shirley R.M., Kunz D.F., Moser S.A., Baddley J.W. Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents. Epidemiol Infect 2011, 139:1342-1350.
36. Richters A., van Vliet M., Peer P.G., Verweij P.E., Laros-van Gorkom B.A., et al. Incidence of and risk factors for persistent Gram-positive bacteraemia and catheter-related thrombosis in haematopoietic stem cell transplantation. Bone Marrow Transplant 2014, 49:264-269.
37. Demiraslan H., Sevim M., Pala Ç., Durmaz S., Berk V., Kaynar L., et al. Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology-oncology patients. Int J Hematol 2013, 97:414-420.